Andrew Cooper - "I am absolutely delighted to be appointed as Clinical Director for the Innovation Agency"
Health Innovation North West Coast has appointed Andrew Cooper as Clinical Director, three years after he joined the organisation as Associate Director of Patient Safety.
Andrew has over 25 years’ experience in the NHS, starting as a registered nurse, specialising in community care and more recently as a senior manager in commissioning, working across health and social care sectors.
His role at the Innovation Agency includes responsibility for delivering improvement programmes commissioned by NHS England and Improvement – in maternity and neonatal care; in early identification of patient deterioration in all care settings; in mental health; in medicines safety; and adoption and spread of innovations.
Innovation Agency Chief Executive Dr Phil Jennings said:
“Andrew has been an outstanding Associate Director, leading major programmes of patient safety improvement and building strong relationships within our region and with our national partners and commissioners.
“I know he will excel in his new role as a strategic, executive leader and influencer – and a role model for Innovation Agency staff from both clinical and non-clinical backgrounds.”
Andrew said: “I am absolutely delighted to be appointed as Clinical Director for the Innovation Agency and I feel incredibly lucky to be able to take on this senior leadership role in such a fantastic organisation. We have an incredible team of dedicated people and we will strive to support ongoing improvements in care, adoption of innovation and economic growth through collaborative work with our partners across our region.”
News and blogs >
Mersey Burns: successful innovator/clinician collaboration Read more
Professor Rowan Pritchard Jones, decided he needed to take action to help treat patients with traumatic burns injuries more safely: by automating the calculation of fluid balance requirements for burns victims, which is critical to survival.
Collaborating for medicines safety Read more
A programme to reduce the avoidable harm caused by opioids is now on a firm footing in the North West Coast.
Launch of new lipid management pathway Read more
Clinicians in Cheshire and Merseyside have collaborated on a new lipid management pathway aimed at improving outcomes for people with cardiovascular disease (CVD).
Mental health innovators to benefit from £20m programme Read more
Health Innovation North West Coast is backing a programme to support innovators working at the forefront of mental health therapeutics
